Literature DB >> 32533509

Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence.

Olga Karapanou1, Marinella Tzanela2, Phoebe Rondogianni3, Catherine Dacou-Voutetakis4, Dimitrios Chiotis4, Barbara Vlassopoulou2, Dimitra Vassiliadi2, Christina Kanaka-Gantenbein4, Stylianos Tsagarakis2.   

Abstract

PURPOSE: Differentiated thyroid cancer (DTC) has an increasing incidence in childhood and adolescence but long-term outcome data are limited. We aimed to identify possible risk factors associated with disease persistence, with special focus on the usefulness of ATA risk stratification system and pre-ablation stimulated thyroglobulin (Tg) levels.
METHODS: We retrospectively studied 103 patients, 79 females (76.7%), aged 15.6 ± 3.2 years (range 5-21 years) who underwent total thyroidectomy for DTC. Patients were classified by ATA risk stratification criteria as low, intermediate, and high risk for recurrence. All, except five with papillary microcarcinoma, received radioactive iodine (RAI) treatment.
RESULTS: At diagnosis, 44.7% of patients had cervical lymph node and 7.8% pulmonary metastases. Amongst the 72 patients with long-term follow-up data, 31.9% had persistent disease. Lymph node as well as pulmonary metastases and increased pre-ablation stimulated thyroglobulin (Tg) levels were associated with persistent disease. The risk of persistent disease was significantly higher in both the intermediate- (OR 17.95; 95% CI 2.66-120.94, p < 0.01) and high-risk (OR 17.65; 95% CI 4.47-69.74, p < 0.001) groups. ROC curve analysis showed that a pre-ablation Tg level higher than 14 ng/ml had a sensitivity of 94.7% to predict persistence, corresponding to a positive (PPV) and negative predictive values (NPV) of 66.7% and 93.8%, respectively.
CONCLUSIONS: ATA risk stratification was validated in our population of children and young adults with DTC. Moreover, pre-ablation stimulated Tg levels of <14 ng/ml were associated with a low risk of long-term persistence and may therefore serve as a marker to identify patients who may need less intensive surveillance.

Entities:  

Keywords:  Children; Differentiated thyroid cancer; Persistence; Thyroglobulin; Young adults

Mesh:

Substances:

Year:  2020        PMID: 32533509     DOI: 10.1007/s12020-020-02378-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

1.  Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents.

Authors:  Patricia Papendieck; Laura Gruñeiro-Papendieck; Marcela Venara; Oscar Acha; Silvana Maglio; Ignacio Bergadá; Ana Chiesa
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

2.  Thyroid cancer in children: management and outcome experience of a referral center.

Authors:  Aron Popovtzer; Thomas Shpitzer; Gideon Bahar; Raphael Feinmesser; Karol Segal
Journal:  Otolaryngol Head Neck Surg       Date:  2006-10       Impact factor: 3.497

Review 3.  Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review.

Authors:  Melissa Pawelczak; Raphael David; Bonita Franklin; Marion Kessler; Leslie Lam; Bina Shah
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

4.  Childhood and adolescent cancer statistics, 2014.

Authors:  Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-31       Impact factor: 508.702

5.  Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.

Authors:  Ian D Hay; Tomas Gonzalez-Losada; Megan S Reinalda; Jennifer A Honetschlager; Melanie L Richards; Geoffrey B Thompson
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

6.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; Marie R Griffin; John E Phay
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

7.  Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.

Authors:  Anthony R Hogan; Ying Zhuge; Eduardo A Perez; Leonidas G Koniaris; John I Lew; Juan E Sola
Journal:  J Surg Res       Date:  2009-05-08       Impact factor: 2.192

8.  Surgical experience in children with differentiated thyroid carcinoma.

Authors:  Jan Willem Haveman; Karin M van Tol; Catrienus W Rouwé; Do A Piers; John T M Plukker
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

9.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

10.  Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer.

Authors:  Fernanda Vaisman; Daniel Alves Bulzico; Cencita Hosannah Cordeiro Noronha Pessoa; Maria Alice Neves Bordallo; Ullyanov Bezerra Toscano de Mendonça; Fernando Luiz Dias; Claudia Medina Coeli; Rossana Corbo; Mario Vaisman
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

View more
  3 in total

1.  Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Yan Gui; Dongmei Huang; Yun Hou; Xudong Wei; Jinming Zhang; Junyi Wang
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

2.  The Role of American Thyroid Association Pediatric Thyroid Cancer Risk Stratification and BRAFV600E Mutation in Predicting thezzm321990Response to Treatment in Papillary Thyroid Cancer Patients ≤18 Years Old

Authors:  Yasemin Giles Şenyürek; Yalın İşcan; İsmail Cem Sormaz; Şükran Poyrazoğlu; Fatih Tunca
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-02-09

3.  Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Padmanaban Annaiyappanaidu; Nabil Siraj; Wael Haqawi; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.